Clinical Trials Sponsored by Kazakh Research Institute of Oncology & Radiology

Total 287 results

National Institute of Cardiology, Warsaw, Poland
Medical Research Agency, Poland

Recruiting

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure (SAFE-LAAC)

Atrial Fibrillation

Poland
Federal State Budgetary Scientific Institution,...
Pfizer

Completed

The First Russian Observational Survey of Heart Failure Patients With Atrial Fibrillation (RIF-CHF)

Atrial Fibrillation | Chronic Heart Failure

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents (OZONE-V)

Chemotherapy-induced Nausea and Vomiting

Russian Federation
Maria Sklodowska-Curie National Research Institute...
KCRI

Not yet recruiting

Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes (CLARA)

Acute Myeloid Leukemia Myelodysplastic Syndromes

Poland
Federal Research Institute of Pediatric Hematology...

Recruiting

DWI in the Diagnosis of Histological Types of Nephroblastoma in Children

Nephroblastoma (Wilms Tumour)

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation

Langerhans Cell Histiocytosis

Russian Federation
Institute of Oncology Ljubljana
Slovenian Research and Innovation Agency

Enrolling by invitation

Electrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous Melanoma

Cutaneous Malignant Melanoma

Slovenia
Federal Research Institute of Pediatric Hematology...

Completed

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Lymphoma | Myelodysplastic Syndromes | Leukemia | Opportunistic Infections | GvHD | Graft-versus-Host Disease

Russian Federation
Federal Research Institute of Pediatric Hematology...

Active, not recruiting

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

B-cell Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia, Pediatric

Russian Federation
Federal Research Institute of Pediatric Hematology...

Completed

Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.

Wiskott-Aldrich Syndrome

Russian Federation
Federal Research Institute of Pediatric Hematology...

Completed

IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease

Chronic Granulomatous Disease

Russian Federation
Federal Research Institute of Pediatric Hematology...

Unknown

Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors

Inflammatory Myofibroblastic Tumor

Russian Federation
Federal Research Institute of Pediatric Hematology...

Completed

Clinical Use of Pathogen Reduced Red Blood Cell Suspension

Hematologic Diseases | Oncologic Disorders

Russian Federation
Federal Research Institute of Pediatric Hematology...

Completed

Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation (45RA_NEG_DLI)

Leukemia, Myeloid, Acute | Opportunistic Infections | Graft vs Host Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Bone Marrow Failure Syndromes | Immune Deficiency Disease

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma

Neuroblastoma | Ganglioneuroblastoma

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)

Juvenile Nasopharyngeal Angiofibroma

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia, in Relapse | Non-hodgkin Lymphoma | High Risk Acute Myeloid Leukemia | High Risk Acute Lymphoblastic Leukemia | Acute Biphenotypic Leukemia in Relapse

Russian Federation
Maria Sklodowska-Curie National Research Institute...
KCRI

Not yet recruiting

Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment (NIVONASO-21)

Nasopharyngeal Cancer

Poland
Federal Research Institute of Pediatric Hematology...

Recruiting

MRI T2* Mapping of Myocardium, Liver, Pancreas and Pituitary Gland

Iron Overload

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Evaluation of Brain Changes in ALL Patients on Therapy

Acute Leukemia

Russian Federation
Federal Research Institute of Pediatric Hematology...

Not yet recruiting

Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia

Acute Leukemia
Federal Research Institute of Pediatric Hematology...

Not yet recruiting

Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy

Aplastic Anemia | Aplastic Anemia Idiopathic
Federal Research Institute of Pediatric Hematology...

Recruiting

Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot

Childhood Acute Lymphoblastic Leukemia

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Modification of the Human Colon and Oral Microbiome by Allogenic HSCT

Human Microbiome | HSCT

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015) (ALL-MB 2015)

Childhood Acute Lymphoblastic Leukemia

Armenia, Belarus, Kyrgyzstan, Russian Federation, Uzbekistan
Federal Research Institute of Pediatric Hematology...

Completed

Videoocular Assessment of Eye Movement Activity in an Ataxia Telangiectasia

Ataxia Telangiectasia | Dysmetria

Russian Federation
Federal Research Institute of Pediatric Hematology...

Active, not recruiting

Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)

Coronavirus Disease 2019

Russian Federation
Federal Research Institute of Pediatric Hematology...

Unknown

Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.

Interstitial Lymphocytic Lung Disease

Russian Federation
Federal Research Institute of Pediatric Hematology...

Unknown

Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008 (ALL-MB 2008)

Childhood Acute Lymphoblastic Leukemia

Russian Federation, Belarus, Uzbekistan
Federal Research Institute of Pediatric Hematology...

Unknown

Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients

Chronic Granulomatous Disease

Russian Federation
Federal Research Institute of Pediatric Hematology...

Completed

Cognitive and Motor Training in Pediatric Posterior Fossa Tumor Survivors

Cognitive Impairment | Childhood Cancer | Motor Skills Disorders | Posterior Fossa Tumor

Russian Federation
Federal Research Institute of Pediatric Hematology...

Unknown

A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Hematopoietic Stem Cell Transplantation | Wiskott-Aldrich Syndrome | Graft Failure

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome

Nijmegen Breakage Syndrome

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Inborn Errors of Immunity

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies

Primary Immunodeficiency Diseases (PID)

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Burkitt Lymphoma | Diffuse Large B-cell Lymphoma | Primary CNS Lymphoma | Primary Mediastinal Lymphoma | Non-hodgkin Lymphoma,B Cell

Russian Federation
Federal Research Institute of Pediatric Hematology...

Not yet recruiting

Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)

Acute Lymphoblastic Leukemia, Pediatric | ALL, Infants
Maria Sklodowska-Curie National Research Institute...
KCRI

Not yet recruiting

Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 OVERALL (PALG ALL7)

CD20-positive Acute Lymphoblastic Leukemia

Poland
Federal Research Institute of Pediatric Hematology...

Not yet recruiting

Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia

Severe Congenital Neutropenia | GATA2 Deficiency

Russian Federation
Federal Research Institute of Pediatric Hematology...

Not yet recruiting

Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT) (FMT-HSCT)

Antibiotic Resistant Strain

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome

Nijmegen Breakage Syndrome

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

Wiskott-Aldrich Syndrome

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT) (BASALT)

Hodgkin's Lymphoma

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA

Acquired Aplastic Anemia

Russian Federation
Federal Research Institute of Pediatric Hematology...

Active, not recruiting

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

Myelodysplastic Syndromes | Juvenile Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Myeloblastic Leukemia | Malignant Lymphoma | Biphenotypic Acute Leukemia

Russian Federation
Federal Research Institute of Pediatric Hematology...

Active, not recruiting

Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL

B-ALL

Russian Federation
Federal Research Institute of Pediatric Hematology...

Completed

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Primary Immune Deficiency Disorder | Hematopoietic Stem Cell Transplantation

Russian Federation
Federal Research Institute of Pediatric Hematology...

Unknown

Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias

Refractory Acute Myeloid Leukemia | Refractory Acute Lymphoblastic Leukemia

Russian Federation
Federal Research Institute of Pediatric Hematology...

Unknown

Metabolic Syndrome in Childhood Cancer Survivors

Metabolic Syndrome

Russian Federation
Federal Research Institute of Pediatric Hematology...

Unknown

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Anesthesia | Pediatric Cancer | Beta-Thalassemia | Hepatic Metastases | Pediatric Tumor | Pediatric Hepatoblastoma

Russian Federation

Clinical Trials Sponsored by Kazakh Research Institute of Oncology & Radiology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations